| Year |
Citation |
Score |
| 2004 |
Shin YG, Udeani GO, Kosmeder JW, Zhao GM, Dagar S, Onyuksel H, Moriarty RM, Cordell GA, Moon RC, Kinghorn AD, Pezzuto JM. Identification of Degradation Product of Deguelin and Its Stability Using Liquid Chromatography and Electrospray/Mass Spectrometry Journal of Liquid Chromatography and Related Technologies. 27: 1057-1069. DOI: 10.1081/Jlc-120030178 |
0.586 |
|
| 2003 |
Dagar S, Rubinstein I, Onyüksel H. Liposomes in ultrasound and gamma scintigraphic imaging. Methods in Enzymology. 373: 198-214. PMID 14714405 DOI: 10.1016/S0076-6879(03)73013-4 |
0.592 |
|
| 2003 |
Dagar S, Onyüksel H, Akhter S, Krishnadas A, Rubinstein I. Human galanin expresses amphipathic properties that modulate its vasoreactivity in vivo. Peptides. 24: 1373-80. PMID 14706552 DOI: 10.1016/J.Peptides.2003.08.007 |
0.686 |
|
| 2003 |
Dagar S, Krishnadas A, Rubinstein I, Blend MJ, Onyüksel H. VIP grafted sterically stabilized liposomes for targeted imaging of breast cancer: in vivo studies. Journal of Controlled Release : Official Journal of the Controlled Release Society. 91: 123-33. PMID 12932644 DOI: 10.1016/S0168-3659(03)00242-6 |
0.67 |
|
| 2003 |
Yeomans DC, Onyüksel H, Dagar S, Ikezaki H, Lu Y, Rubinstein I. Conformation-dependent effects of VIP on nociception in rats. Peptides. 24: 617-22. PMID 12860207 DOI: 10.1016/S0196-9781(03)00102-5 |
0.329 |
|
| 2003 |
Onyüksel H, Ashok B, Dagar S, Sethi V, Rubinstein I. Interactions of VIP with rigid phospholipid bilayers: implications for vasoreactivity. Peptides. 24: 281-6. PMID 12668213 DOI: 10.1016/S0196-9781(03)00033-0 |
0.717 |
|
| 2001 |
Dagar S, Sekosan M, Lee BS, Rubinstein I, Onyüksel H. VIP receptors as molecular targets of breast cancer: implications for targeted imaging and drug delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society. 74: 129-34. PMID 11489489 DOI: 10.1016/S0168-3659(01)00326-1 |
0.665 |
|
| 2001 |
Rubinstein I, Chandilawa R, Dagar S, Hong D, Gao XP. Adenosine A(1) receptors mediate plasma exudation from the oral mucosa. Journal of Applied Physiology (Bethesda, Md. : 1985). 91: 552-60. PMID 11457765 DOI: 10.1152/Jappl.2001.91.2.552 |
0.3 |
|
| 2001 |
Rubinstein I, Dagar S, Sethi V, Krishnadas A, Onyüksel H. Liposomal VIP potentiates DNA synthesis in cultured oral keratinocytes. Peptides. 22: 671-5. PMID 11311738 DOI: 10.1016/S0196-9781(01)00377-1 |
0.626 |
|
| 2001 |
Dagar S, Sekosan M, Rubinstein I, Onyüksel H. Detection of VIP receptors in MNU-induced breast cancer in rats: implications for breast cancer targeting. Breast Cancer Research and Treatment. 65: 49-54. PMID 11245339 DOI: 10.1023/A:1006406617497 |
0.643 |
|
| 2000 |
Onyüksel H, Bodalia B, Sethi V, Dagar S, Rubinsteina I. Surface-active properties of vasoactive intestinal peptide*. Peptides. 21: 419-23. PMID 10793226 DOI: 10.1016/S0196-9781(00)00161-3 |
0.743 |
|
| 1999 |
Rubinstein I, Patel M, Ikezaki H, Dagar S, Onyüksel H. Conformation and vasoreactivity of VIP in phospholipids: effects of calmodulin. Peptides. 20: 1497-501. PMID 10698126 DOI: 10.1016/S0196-9781(99)00161-8 |
0.656 |
|
| 1998 |
Demos SM, Dagar S, Klegerman M, Nagaraj A, McPherson DD, Onyuksel H. In vitro targeting of acoustically reflective immunoliposomes to fibrin under various flow conditions. Journal of Drug Targeting. 5: 507-18. PMID 9783681 DOI: 10.3109/10611869808997876 |
0.587 |
|
| Show low-probability matches. |